Digitala Vetenskapliga Arkivet

Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Patienters attityder och åsikter kring generisk substitution
Linnéuniversitetet, Fakulteten för Hälso- och livsvetenskap (FHL), Institutionen för kemi och biomedicin (KOB).
2016 (Svenska)Självständigt arbete på grundnivå (kandidatexamen), 10 poäng / 15 hpStudentuppsats (Examensarbete)
Abstract [en]

The Swedish drug expenses increased sharply during the 1990. The increase in cost of drug spending declined from year 2002, due to the introduction of generic substitution. ‘Generic substitution’ is a pharmaceutical term used to describe the substitution of a prescribed drug (that has an expired patent) with an equivalent alternative containing the same drug substance, formulation and strength. The substituted drug has similar bioavailability, and are approved as generics by “Läkemedelsverket” (compare EMA, FDA)

This substitution of drugs has led to an eight million Swedish kronor reduction in annual costs on government drug spending. Money that can be allocated to other sectors in the healthcare system.

Despite these huge savings, patients have been criticizing the generic exchange system due to perceived side effects, suspicion of a lower quality and uncertainty and confusion about what drugs to use. This might add up to poorer compliance, risk for double-medication and medicinal errors. Johan Wallér, CEO of Apoteksföreningen (a lobbying organization for pharmacy retailers), claims that an estimate of 200.000 people every year are making errors when medicating, and experience an inferior medical effect due to generic exchange.

The aim of this study was to identify the problems and opportunities experienced by patients due to the introduction of generic substitution. A questionnaire study was performed including 280 customers, presenting prescriptions on drugs available for drug substitution in five different pharmacies, in Malmo (town in the southern part of Sweden).

In the survey, questions were asked about what knowledge the customers had of generic substitution and from whom they had received this information. Questions were also asked about medical errors.

The results from the questionnaire show that 5/280 had experienced problem with generic substitution that had had impact on their well-being. Also, patients over 56 on a long-term medication, and with multiple interchangeable medicines often run into problems with generic exchange. The patients in the survey reported a shortage/lack of communication and information from the doctors about the pros and cons with generic drugs.

Some patients were confused about package looking different from what they were used to, different size, form and colour of tablets.  Approximately 46 % of the patients consider the shape of tablets to be important, and 23 % said the size. Changing the shape and size of tablets may therefore have negative consequences.

There is a risk of medication errors associated with the use of generics. In this survey, few people experienced side effect, but on a national basis this problem cannot be ignored, since millions of prescriptions are subject to generic substitution. This calls for the need of informing the customers in pharmacies and by physicians in a proper way.

Ort, förlag, år, upplaga, sidor
2016. , s. 49
Nyckelord [sv]
Generisk substitution
Nationell ämneskategori
Medicin och hälsovetenskap
Identifikatorer
URN: urn:nbn:se:lnu:diva-59554OAI: oai:DiVA.org:lnu-59554DiVA, id: diva2:1060760
Ämne / kurs
Farmaci
Utbildningsprogram
Farmaceutprogrammet, 180 hp
Handledare
Examinatorer
Tillgänglig från: 2016-12-30 Skapad: 2016-12-29 Senast uppdaterad: 2016-12-30Bibliografiskt granskad

Open Access i DiVA

fulltext(2757 kB)585 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 2757 kBChecksumma SHA-512
39eb878c8f3ba433f8a00c568c7823daccc61f05401b3a6825821ee64afd18908c0ef13da8228027bd53c6b55603aa1c2cc336ff6156508575d3fd48ab305eca
Typ fulltextMimetyp application/pdf

Sök vidare i DiVA

Av författaren/redaktören
Sahebezai, Benazir
Av organisationen
Institutionen för kemi och biomedicin (KOB)
Medicin och hälsovetenskap

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 585 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

urn-nbn

Altmetricpoäng

urn-nbn
Totalt: 377 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf